Liu W - Search Results

1

Oxaliplatin-Resistant Hepatocellular Carcinoma Drives Immune Evasion Through PD-L1 Up-Regulation and PMN-Singular Recruitment.

Zhang F, Hu K, Liu W, Quan B, Li M, Lu S, Chen R, Ren Z, Yin X. Zhang F, et al. Among authors: liu w. Cell Mol Gastroenterol Hepatol. 2023;15(3):573-591. doi: 10.1016/j.jcmgh.2022.12.002. Epub 2022 Dec 10. Cell Mol Gastroenterol Hepatol. 2023. PMID: 36513250 Free PMC article.

2

The prognostic significance of microRNA-221 in hepatocellular carcinoma: An updated meta-analysis.

Liu W, Hu K, Zhang F, Lu S, Chen R, Ren Z, Yin X. Liu W, et al. Int J Biol Markers. 2021 Jun;36(2):17246008211032689. doi: 10.1177/17246008211032689. Int J Biol Markers. 2021. PMID: 34374576 Free article.

3

The Prognostic Value of the Albumin to Gamma-Glutamyltransferase Ratio in Patients with Hepatocellular Carcinoma Undergoing Radiofrequency Ablation.

Liu W, Zhang F, Quan B, Li M, Lu S, Li J, Chen R, Yin X. Liu W, et al. Dis Markers. 2021 Nov 19;2021:3514827. doi: 10.1155/2021/3514827. eCollection 2021. Dis Markers. 2021. PMID: 34840628 Free PMC article.

4

First-Line Systemic Treatment Strategies for Unresectable Hepatocellular Carcinoma: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.

Liu W, Quan B, Lu S, Tang B, Li M, Chen R, Ren Z, Yin X. Liu W, et al. Front Oncol. 2021 Dec 24;11:771045. doi: 10.3389/fonc.2021.771045. eCollection 2021. Front Oncol. 2021. PMID: 35004289 Free PMC article.

5

Zhang F, Cai J, Hu K, Liu W, Lu S, Tang B, Li M, Wu W, Ren Z, Yin X. Zhang F, et al. Among authors: liu w. Comb Chem High Throughput Screen. 2022;25(13):2203-2216. doi: 10.2174/1386207325666220304115006. Comb Chem High Throughput Screen. 2022. PMID: 35249477

6

Predicting Disease-Specific Survival for Patients With Primary Cholangiocarcinoma Undergoing Curative Resection by Using a Decision Tree Model.

Quan B, Li M, Lu S, Li J, Liu W, Zhang F, Chen R, Ren Z, Yin X. Quan B, et al. Among authors: liu w. Front Oncol. 2022 Apr 21;12:824541. doi: 10.3389/fonc.2022.824541. eCollection 2022. Front Oncol. 2022. PMID: 35530339 Free PMC article.

7

PVR-A Prognostic Biomarker Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma.

Liu WF, Quan B, Li M, Zhang F, Hu KS, Yin X. Liu WF, et al. Diagnostics (Basel). 2022 Nov 25;12(12):2953. doi: 10.3390/diagnostics12122953. Diagnostics (Basel). 2022. PMID: 36552960 Free PMC article.

8

Gas7 attenuates hepatocellular carcinoma progression and chemoresistance through the PI3K/Akt signaling pathway.

Liu WF, Zhang QW, Quan B, Zhang F, Li M, Lu SX, Dong L, Yin X, Liu BB. Liu WF, et al. Cell Signal. 2023 Dec;112:110908. doi: 10.1016/j.cellsig.2023.110908. Epub 2023 Sep 27. Cell Signal. 2023. PMID: 37769891

9

LINC02362/hsa-miR-18a-5p/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma.

Quan B, Liu W, Yao F, Li M, Tang B, Li J, Ren Z, Yin X. Quan B, et al. Among authors: liu w. Am J Cancer Res. 2023 Nov 15;13(11):5590-5609. eCollection 2023. Am J Cancer Res. 2023. PMID: 38058825 Free PMC article.

10

NLRP3/IL-1β induced myeloid-derived suppressor cells recruitment and PD-L1 upregulation promotes oxaliplatin resistance of hepatocellular carcinoma.

Liu W, Zhang F, Quan B, Yao F, Chen R, Ren Z, Yin X. Liu W, et al. MedComm (2020). 2023 Dec 19;4(6):e447. doi: 10.1002/mco2.447. eCollection 2023 Dec. MedComm (2020). 2023. PMID: 38116060 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59,702 results

Search Page

Filters